Our new issue is live! Click below for more on the value of treatment for #CML (cover art inspiration), sirolimus for #GVHD prophylaxis, ibrutinib plus FCR for #CLL & obinutuzumab plus lenalidomide in follicular B-cell #lymphoma | #leusm#lymsmhttps://t.co/WMhT8YE1Hz